Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase I/II Trial of Stereotactic Body Proton Therapy for Patients With Liver Metastases

The purpose of the phase I/II study is evaluate the safety and feasibility of stereotactic body proton therapy in patients with liver metastases.

NCT#: NCT01697371
Study ID: 5120022
Trial Phase: Phase I/II

Trial Sponsor: Loma Linda University, Gary Yang, MD
Therapies Used in This Trial: Proton Radiation

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Back to Trial Search